Wogonoside induces cell cycle arrest and mitochondrial mediated apoptosis by modulation of Bcl-2 and Bax in osteosarcoma cancer cells

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 1, 2015, Pages 63-72

  Wang, Yang ^a   Yin, Ruo Feng ^a   Teng, Jia Song ^b  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b Daqing Oilfield General Hospital   (China)

Author keywords

Apoptosis; Cell cycle; Mitochondria; Osteosarcoma; Wogonoside

Indexed keywords

ANTINEOPLASTIC AGENT; FLAVANONE DERIVATIVE; GLUCOSIDE; PROTEIN BAX; PROTEIN BCL 2; WOGONOSIDE;

APOPTOSIS; BONE TUMOR; CELL CYCLE CHECKPOINT; CELL SURVIVAL; DRUG EFFECTS; FLOW CYTOMETRY; HUMAN; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; OSTEOSARCOMA; PATHOLOGY; PHASE CONTRAST MICROSCOPY; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; BONE NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL SURVIVAL; FLAVANONES; FLOW CYTOMETRY; GLUCOSIDES; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, PHASE-CONTRAST; OSTEOSARCOMA; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84922975788     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Chou AJ, Geller DS, Gorlick R. Therapy for osteosarcoma: where do we go from here? Paediatr Drugs 2008; 10: 315-327.
2. Dai X, Ma W, He X, Jha RK. Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma. Med Sci Monit 2011; 17: 177-190.
3. Kim SY, Helman LJ. Strategies to explore new approaches in the investigation and treatment of osteosarcoma. Cancer Treat Res 2009; 152: 517-528.
4. Hattinger CM, Pasello M, Ferrari S, Picci P, Serra M. Emerging drugs for high-grade osteosarcoma. Expert Opin Emerg Drugs 2010; 15: 615-634.
5. Mehta RG, Murillo G, Naithani R, Peng X. Cancer chemoprevention by natural products: how far have we come? Phar Res 2010; 27: 950-961.
6. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007; 70: 461-477.
7. Verhoven B, Schlegel RA, Williamson P. Me-chanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995; 182: 1597-1601.
8. Rasola A, Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 2007; 12: 815-833.
9. Reed JC. Double identity for proteins of the Bcl-2 family. Nature 1997; 387: 773-776.
10. Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol 1998; 16: 395-419.
11. Kluck RM, Bossy-Wetzel E, Green DR, New-meyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132-1136.
12. Hen Y, Hui H, Yang H, Zhao K, Qin Y, Gu C, Wang X, Lu N, Guo Q. Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PL-SCR1 in AML cells. Blood 2013; 121: 3682-91.
13. Sun Y, Zou M, Hu C, Qin Y, Song X, Lu N, Guo Q. Wogonoside induces autophagy in MDA-MB-231 cells by regulating MAPK-mTOR pathway. Food Chem Toxicol 2013; 51: 53-60.
14. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999; 399: 483-487.
15. Bossy-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 1998; 17: 37-49.